시장보고서
상품코드
1936782

임상의사결정지원시스템 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

Global Clinical Decision Support System Market Size, Share, Trends & Growth Analysis Report 2026-2034

발행일: | 리서치사: Value Market Research | 페이지 정보: 영문 173 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

임상의사결정지원시스템(CDSS) 시장 규모는 2025년 37억 1,000만 달러에서 2034년에는 104억 1,000만 달러에 달할 것으로 예측되고 있으며, 2026-2034년에 CAGR 12.14%로 성장할 전망입니다.

세계 임상의사결정지원시스템(CDSS) 시장은 의료 성과 향상에 대한 수요 증가와 효율적인 임상 워크플로우에 대한 요구로 인해 큰 폭의 성장이 예상됩니다. CDSS 툴은 환자 치료 중 근거에 기반한 권장 사항, 경고 및 알림을 제공하여 의료진이 정보에 입각한 의사결정을 내릴 수 있도록 지원합니다. 의료 서비스 프로바이더들이 환자 안전을 개선하고 오류를 줄이며 치료 계획을 최적화하기 위해 노력함에 따라 CDSS의 도입이 크게 증가하여 이 중요한 시장에서 혁신과 투자를 촉진할 것으로 예측됩니다.

또한 인공지능(AI)과 머신러닝의 발전은 CDSS의 영역을 변화시킬 것으로 예측됩니다. 이러한 기술의 통합은 고급 데이터 분석을 가능하게 하고, CDSS가 개별 환자 데이터와 임상 가이드라인에 기반한 개인화된 추천을 제공할 수 있게 해줍니다. 또한 가치 기반 의료와 집단건강관리에 대한 관심이 높아지면서 대규모 데이터세트를 분석하여 동향을 파악하고 환자 결과를 개선할 수 있는 CDSS 솔루션에 대한 수요가 증가하고 있습니다. 의료 산업이 계속 발전함에 따라 임상적 의사결정을 지원하고 전반적인 의료 서비스의 질을 향상시키는 혁신적인 솔루션에 대한 수요가 급증할 가능성이 높습니다.

또한 규제 준수와 상호운용성에 대한 관심이 높아지면서 CDSS 시장 전망를 좌우할 것으로 예측됩니다. 정부와 의료기관이 데이터 보안 및 환자 프라이버시 규제를 강화함에 따라 이러한 기준을 준수하는 CDSS 솔루션에 대한 수요는 계속 증가할 것입니다. 기술 프로바이더, 의료 기관, 규제 당국 간의 협력적 노력은 이러한 발전을 촉진하고 임상의사결정지원시스템 시장이 의료 프로바이더와 환자의 진화하는 요구에 부응하기 위해 필수적입니다.

목차

제1장 서론

제2장 개요

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 임상의사결정지원시스템 시장 : 컴포넌트별

제5장 세계의 임상의사결정지원시스템 시장 : 제공 모드별

제6장 세계의 임상의사결정지원시스템 시장 : 용도별

제7장 세계의 임상의사결정지원시스템 시장 : 최종사용자별

제8장 세계의 임상의사결정지원시스템 시장 : 지역별

제9장 경쟁 구도

제10장 기업 개요

KSA 26.03.19

The Clinical Decision Support System Market size is expected to reach USD 10.41 Billion in 2034 from USD 3.71 Billion (2025) growing at a CAGR of 12.14% during 2026-2034.

The global clinical decision support system (CDSS) market is poised for significant growth, driven by the increasing demand for improved healthcare outcomes and the need for efficient clinical workflows. CDSS tools assist healthcare professionals in making informed decisions by providing evidence-based recommendations, alerts, and reminders during patient care. As healthcare providers strive to enhance patient safety, reduce errors, and optimize treatment plans, the adoption of CDSS is expected to rise substantially, fostering innovation and investment in this critical market.

Moreover, advancements in artificial intelligence (AI) and machine learning are set to transform the CDSS landscape. The integration of these technologies allows for more sophisticated data analysis, enabling CDSS to provide personalized recommendations based on individual patient data and clinical guidelines. Additionally, the growing emphasis on value-based care and population health management is driving the demand for CDSS solutions that can analyze large datasets to identify trends and improve patient outcomes. As the healthcare industry continues to evolve, the market for clinical decision support systems is likely to witness a surge in demand for innovative solutions that enhance clinical decision-making and improve overall healthcare delivery.

In addition, the increasing focus on regulatory compliance and interoperability is expected to shape the future of the CDSS market. As governments and healthcare organizations implement stricter regulations regarding data security and patient privacy, the demand for CDSS solutions that comply with these standards will continue to rise. Collaborative efforts between technology providers, healthcare institutions, and regulatory bodies will be essential in driving these advancements, ensuring that the clinical decision support system market remains responsive to the evolving needs of healthcare providers and patients.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Component

  • Software
  • Hardware
  • Services

By Delivery Mode

  • On-Premise
  • Cloud-Based

By Application

  • Drug Databases
  • Care Plans
  • Diagnostic Decision Support
  • Disease Reference
  • Others

By End-User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

COMPANIES PROFILED

  • McKesson Corporation, Siemens Healthineers, IBM Watson Health, Hearst Health, Cerner Corporation, Wolters Kluwer Health, Philips Healthcare, Elsevier BV, Veradigm Inc formerly Allscripts Healthcare Solutions Inc, NextGen Healthcare Information Systems LLC, Meditech, GE Healthcare, Change Healthcare, Athenahealth Inc, Optum Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET: BY COMPONENT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Component
  • 4.2. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Hardware Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET: BY DELIVERY MODE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Delivery Mode
  • 5.2. On-Premise Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Cloud-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Drug Databases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Care Plans Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Diagnostic Decision Support Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Disease Reference Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET: BY END-USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-user
  • 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CLINICAL DECISION SUPPORT SYSTEM MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Component
    • 8.2.2 By Delivery Mode
    • 8.2.3 By Application
    • 8.2.4 By End-user
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Component
    • 8.3.2 By Delivery Mode
    • 8.3.3 By Application
    • 8.3.4 By End-user
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Component
    • 8.4.2 By Delivery Mode
    • 8.4.3 By Application
    • 8.4.4 By End-user
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Component
    • 8.5.2 By Delivery Mode
    • 8.5.3 By Application
    • 8.5.4 By End-user
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Component
    • 8.6.2 By Delivery Mode
    • 8.6.3 By Application
    • 8.6.4 By End-user
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CLINICAL DECISION SUPPORT SYSTEM INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 McKesson Corporation
    • 10.2.2 Siemens Healthineers
    • 10.2.3 IBM Watson Health
    • 10.2.4 Hearst Health
    • 10.2.5 Cerner Corporation
    • 10.2.6 Wolters Kluwer Health
    • 10.2.7 Philips Healthcare
    • 10.2.8 Elsevier B.V
    • 10.2.9 Veradigm Inc. (Formerly Allscripts Healthcare Solutions Inc.)
    • 10.2.10 NextGen Healthcare Information Systems LLC
    • 10.2.11 Meditech
    • 10.2.12 GE Healthcare
    • 10.2.13 Change Healthcare
    • 10.2.14 Athenahealth Inc
    • 10.2.15 Optum Inc
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제